ARCHIVE

• GSK to Revise Promotion Strategy for Imigran
  July 21, 2003

• REGULATORY NEWS IN BRIEF
  July 21, 2003

• Meiji Seika's GE Business Showing Steady Progress
  July 21, 2003

• MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
  July 21, 2003

• Towa Pharm Launches 13 GEs; \2.9 Bil. in Sales Projected
  July 21, 2003

• J-TEC to Accelerate Commercialization of Autologous Cultured Skin, Cartilage
  July 21, 2003

• Nichiiko Using Multiple Supply Routes for Pravastatin
  July 21, 2003

• Use of Dedicated Spring-8 Beam Line Activated
  July 21, 2003

• Teikoku Hormone to Aggressively Develop GE Business
  July 21, 2003

• PRESS SEMINAR
  July 21, 2003

• Elmed Eisai Reports Strong Growth, First Profits
  July 21, 2003

• OTC NEWS IN BRIEF
  July 21, 2003

• Toyobo Working to Develop Global Biomedical Business
  July 21, 2003

• DIAGNOSTIC NEWS IN BRIEF
  July 21, 2003

• Teijin Enters into License Agreement with Ipsen
  July 21, 2003

• MEDICAL DEVICE NEWS IN BRIEF
  July 21, 2003

• Fukujin Aims to Be No. 1 Wholesaler 3 Years After Merger
  July 21, 2003

• Kringle Pharma Hopes for Global Expansion via Alliances
  July 21, 2003

• Versions of Mevalotin, Lipovas Launched by All 4 Top GE Houses
  July 14, 2003

• Tsuruha: Sales Increase 14.8% to \116 Bil.
  July 14, 2003

ページ

• « 先頭
• ‹ Prev
• …
• 586
• 587
• 588
• 589
• 590
• 591
• 592
• 593
• 594
• …
• Next ›
• 最終 »